Location & Type arrow_drop_up Concepts arrow_drop_down Orgs arrow_drop_down
#1
Cancer Biotherapy Research Group
Cancer Biotherapy Research Group
Known for star star star star star
Monoclonal Antibody | Cancer Cells | Autologous Tumor | Chronic Lymphocytic
#2
ROBERT O. DILLMAN
ROBERT O. DILLMAN
Known for star star star star star
Monoclonal Antibody | Autologous Tumor | Indolent Lymphoma | Interferon Alfa

#3
German Low Grade Lymphoma Study Group
German Low Grade Lymphoma Study Group
Known for star star star star star
Maintenance Therapy | Follicular Lymphoma | Involved Field | Myeloablative Radio
#4
Jan A Walewski
Jan A Walewski
Known for star star star star star_half
Chop Induction | Indolent Lymphoma | Months Chemotherapy | Response Rates
#5
Gianluca Gaidano
Gianluca Gaidano
Division of Hematology, BRMA - Amedeo Avogadro Unversity of Eastern Piedmont, Novara, Italy
Known for star star star star star_border
Mcl0208 Trial | Rituximab Lenalidomide | Lymphoid Leukemia | Richter Transformation
#6
Changchun Deng
Changchun Deng
Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, New York
Known for star star star star star_border
Follicular Lymphoma | Tgr-1202 Relapsed | Phase Carfilzomib | Primary Objective
#7
I Divisione di Malattie Infettive, Ospedale Luigi
I Divisione di Malattie Infettive, Ospedale Luigi
Department of Medical Biotechnologies, Section of Pathology, University of Siena, Siena, Italy
Known for star star star star star_border
Rituximab Lenalidomide | Relapsed Refractory | Follicular Lymphoma | Phase Iii
#8
James Olen Armitage
James Olen Armitage
San Raffaele Scientific Institute, Milan, Italy Oncology Institute of Southern Switzerland, Bellinzona, Switzerland Eppley Cancer Center, University of Nebraska Medical ...
Known for star star star star star_border
Bone Marrow | High-Dose Therapy | Follicular Lymphoma | Chromosomal Abnormalities
#9
Eva K. Kimby
Eva K. Kimby
Department of Medicine, Section of Hematology, Danderyd Hospital, Danderyd, and the Department of Clinical Immunology, Huddinge Hospital, Huddinge, Sweden
Known for star star star star star_border
Follicular Lymphoma | Chronic Lymphocytic Leukemia | Advisory Committees | Rituximab Maintenance
#10
Krimo Bouabdallah
Krimo Bouabdallah
CHU Bordeaux, Service d’Hématologie et Thérapie Cellulaire, Bordeaux, France
Known for star star star star star_border
Advisory Committees | Entitys Board | Speakers Bureau | Intensive Chemotherapy
#11
Wafaa Al-Shakweer
Wafaa Al-Shakweer
Department of Pathology and Laboratory Medicine, King Fahad Medical City, Riyadh, Saudi Arabia
Known for star star star star star_border
Indolent Lymphoma | Survival Time | Emission Tomography | Initial Diagnosis
#12
Cristine Allmer
Cristine Allmer
Mayo Clinic and Mayo Foundation, Rochester, MN, USA
Known for star star star star star_border
Follicular Lymphoma | 12 Months | Event-Free Survival | Autoimmune Conditions
#13
Nicolas Ketterer
Nicolas Ketterer
Reprints: Philippe Moreau, Hematology Department, University Hospital Hôtel-Dieu, Place Alexis Ricordeau, 44093 Nantes cedex 01, France; e-mail: philippe.moreau{at}chu-nantes.fr.
Known for star star star star star_border
Follicular Lymphoma | Response Rate | Single Agent | Event-Free Survival
#14
James L. Gajewski
James L. Gajewski
From the Departments of Leukemia, Bioimmunotherapy,Biostatistics, and Blood and Bone Marrow Transplantation,M.D. Anderson Cancer Center, Houston, TX; and the National ...
Known for star star star star star_border
Marrow Transplant | High-Dose Chemotherapy | Unrelated Donors | Acute Myelogenous Leukemia
#15
Martin Mohren
Martin Mohren
From University Hospital Magdeburg, Division of Cardiology (A.G., M.A., A.A., H.U.K.), Institute of Experimental Internal Medicine (U.L., C.R), Division of Hematology/Oncology ...
Known for star star star star star_border
Acute Leukaemia | Capillary Blood Count | Corticosteroid Injection | Willebrand Factor
#16
Max M. Wolf
Max M. Wolf
Haematology Research Unit, Department of Pathology, Clinical Immunology & Immunogenetics Unit, Cancer Institute, Melbourne
Known for star star star star star_border
Cd34-Selected Cells | Peripheral Blood | Rituximab Maintenance | Primary Therapy
#17
Stephanie Alicia Terezakis
Stephanie Alicia Terezakis
Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland
Known for star star star star star_border
Radiation Therapy | Hodgkin Lymphoma | Young Adults | Nrg Oncology

 

Recently Asked Questions

View all FAQs

Bipolar Schizophrenia Bipolar schizophrenia is a mental disorder that is characterized by extreme mood swings. People with this condition may experience periods of depression,...

 

Hepatitis A Hepatitis A is a highly contagious liver infection caused by the hepatitis A virus (HAV). The virus is primarily spread when an infected person...

 

Salivary Stones Salivary stones are small, hard deposits that form in the salivary glands. There are three main types of salivary stones: calcified stones, cystic stones,...

 

Preeclampsia Postpartum Preeclampsia is a condition that can occur during pregnancy, typically after the twentieth week. It is characterized by high blood pressure and protein in...

 

Trospium Trospium is a medication used to treat overactive bladder. It works by relaxing the muscles of the bladder and relieving symptoms such as urinary frequency,...

 

Ilyad (Indolent Lymphoma And Vitamin D) A Phase Iii Double Blind, Randomized...

[ CLINICAL_TRIAL ] Despite strong evidence suggesting that vitamin D deficiency is associated with undesirable outcomes in patients with numerous cancers, there has never been a thorough study of vitamin D ...
Known for star star star star star
Indolent Lymphoma | Phase Iii | Free Survival | Evaluate Vitamin

A Multicenter, Single Arm Clinical Trial In Patients With Rituximab Refractory...

[ CLINICAL_TRIAL ] ... B-cell indolent lymphoma. Detailed Description This is multicenter, open label study to evaluate the safety and efficacy of bendamustine HCl in patients with indolent Non-hodgkin's ...
Known for star star star star star
Indolent Lymphoma | Rituximab Refractory | Single Arm | Bendamustine Hcl

Vaccination With Recombinant Lymphoma Idiotype In Indolent Lymphoma In Advanced Stages

[ CLINICAL_TRIAL ] This treatment is designed to activate and enable the immune system for a targeted destruction of the tumor cells. For this purpose, as individual vaccine will be produced from fresh tumor ...
Known for star star star star star_border
Lymphoma Idiotype | Immune Tumor | Vaccine Produced | Trial Examinations

A Cancer Research Uk Phase I Trial Of The Anti-Cd19 Di-B4 Monoclonal Antibody...

[ CLINICAL_TRIAL ] The main aims of this clinical study are to find out the maximum dose that can be given safely to patients, the potential side effects of the drug and how they can be managed. The study will ...
Known for star star star star star_border
Monoclonal Antibody | Advanced Cd19 | Drug Anti | Phase Escalation

Transformed Waldenström Macroglobulinaemia: Clinical Presentation And Outcome. A...

[ CLINICAL_TRIAL ] ... B-cell lymphoma is a rare complication which may occur in Waldenstrom macroglobulinemia. In this multicenter study, we retrospectively analyzed the clinico-biological features, therapy, ...
Known for star star star star star_border
Transformed Waldenström | Waldenstrom Macroglobulinemia | Transformation Diffuse | Lymphoma Retrospectively

Favorable Outcomes From Allogeneic And Autologous Stem Cell Transplantation For...

[ PUBLICATION ] ... transformed indolent nonfollicular non-Hodgkin lymphoma is unknown. This is a multicenter, retrospective cohort study of patients with biopsy-proven indolent B cell nonfollicular ...
Known for star star star star star_border
Transformed Nonfollicular Indolent Lymphoma | Auto Sct | Stem Transplantation | Indolent Histologies

Augment: A Phase Iii Study Of Lenalidomide Plus Rituximab Versus Placebo Plus...

[ PUBLICATION ] ... non-Hodgkin lymphoma typically respond well to first-line immunochemotherapy. At relapse, single-agent rituximab is commonly administered. Data suggest the immunomodulatory agent ...
Known for star star star star star_border
Phase Iii | Indolent Lymphoma | Lenalidomide Rituximab | Progression-Free Survival

Infectious Disease Associations In Advanced Stage, Indolent Lymphoma (Follicular...

[ PUBLICATION ] ... stage indolent lymphoma (follicular; nonfollicular lymphoma) eligible for observation. MATERIALS AND METHODS: Stool H. pylori, hepatitis C and Borrelia serologies, Borrelia and Chlamydia ...
Known for star star star star star_border
Advanced Stage | Indolent Lymphoma | Prevention Strategy | Months Infections

High Serum Interleukin-6 Levels Correlate With A Shorter Failure-Free Survival In...

[ PUBLICATION ] Interleukin-6 (IL-6) is a potent immunomodulatory cytokine that may have pathogenetic and prognostic significance in a number of disorders. The objective of this study was to examine the ...
Known for star star star star star_border
Indolent Lymphoma | Free Survival | Serum Il-6 | Frozen Sera

Fludarabine, Mitoxantrone, And Dexamethasone: An Effective New Regimen For...

[ PUBLICATION ] ... with indolent lymphomas respond to initial therapy, virtually all experience relapse. Secondary therapy is often beneficial, but responses are rarely, if ever, durable. We conducted this ...
Known for star star star star star_border
Indolent Lymphoma | Opportunistic Infections | Toxic Effects | Prior Regimens